SPECIFIC CHARACTERISTICS OF MEDICATED ABORTION – REVIEW
Keywords:
abortion on medical grounds, medical reason, knowledge, schedule of drugs, regulatory requirementsAbstract
Specific characteristics of medicated abortion include the use of medication to terminate a pregnancy. It typically involves taking two medications, mifepristone and misoprostol, in order to induce a miscarriage like process. This method can be used up to 10 weeks into a pregnancy and is considered safe and effective. An analysis of various randomized controlled trials has been performed to evaluate approaches to making decisions about surgical or medicamentosin abortion, which are extremely difficult for our conditions. The main factor besides the medical condition is the regulation .
Purpose: Open research studies and presented articles used as models and frameworks for tracking abortion practices when considering medically related situations, and approaches to clinical medical practice. Most studies deal with the Performing of abortions on demand, a small minority consider the practice of performing abortions on medical grounds.
Results: Monitoring of the conditions for performing an abortion on request or for medical reasons is carried out by the conditions stipulated in several medical documents Medical standard in Obstetrics and Gynecology, The Ordinance on performing an abortion. Regardless of the place of performance, information about performed abortions requires strict accountability and compliance with protocols in Bulgaria. Medical abortion has been a means of choice in different parts of the world for over 20 years, but only in the last few years has it started to be applied in medical institutions in Bulgaria, according to strict indications. Medications are administered according to schedule: Mifepristone (200 mg oral, 24 48hours before the procedure); Misoprostol (400 mg sublingual, 1 2 hours before the procedure or vaginal/ buccal, 2 3hours before the procedure).
In conclusion, Abortion is strictly regulated in Bulgaria. regulatory requirements, conditions and the possibility of performing abortion in the healing structure are observed. In addition, a pregnant woman may perform an abortion on medical grounds under proven conditions and conducted confirmatory tests for the presence of a medical cause.
References
Abramchenko V., Guseva N. (2005), Medicated abortion. Publishing house „ELBI“, ISBN 5-93979-135-2: рр.116.
Arsenijevic S., G. Vukcevic-Globarevic, V. Volarevic, I. Macuzic, P. Todorovic, I. Tanaskovic, M. Mijailovic, S. Raicevic and B. Jeremic. (2012).Continuous controllable balloon dilation: A novel approach for cervix dilation. BioMed Central Ltd. Trials 13:рр.196. http://www.trialsjournal.com/content/13/1/196
Borgatta L., Roncari D., Sonalkar S., Mark A., Hou M.Y., Finneseth M., Vragovic O. (2012). Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14–16 weeks: a randomized trial. Contraception. 86 (5):рр.567-71.
Dikke G. (2018). Medicamentous service abortion in outpatient practice. G ASBOTAR-Media, ISBN 978-5-9704-4430-6: pp.384;
Ipas. (2021). Clinical Updates in Reproductive Health. N. Kapp (1st Ed.). Chapel Hill, NC: Ipas.
Jha B, Jha A. (2019). Assessment of different routes of administration of misoprostol in first and second trimester abortions. International Journal of Medical and Health Research Volume 5; Issue 6, June: рр.166-169.
Kapp N. (2019). Medical abortion in the late first trimester: a systematic review. Contraception. Volume № 99: рр.77–86.
Ministry of Health. (2021). Medical standard for Obstetrics and gynecology, Ordinance Apostille 9 of 27 april 2021, last Amendment and supplement of the state gazette. Issue 63, 30 July 2021.
Ministry of Health. (1990). Ordinance 2 of 01.02.1990 on The terms and conditions for artificial termination of pregnancy, amended and supplemented in the state gazette. Issue 89/31.10.2000.
Radeva S. (2023). Psychological aspects of women's health care abortion on medical grounds. Knowledge - International Journal; 61(4): рр. 777–781.
Radeva S. (2024). Prevention of Induced Abortion - Effect on Pain. Systematic Review of a Database. International Journal of Multidisciplinary Research and Analysis. 7(01): рр.155-158.
Radeva S. (2024). Completed abortion, features. Евразийский союз ученых. Серия: медицинские, биологические и химические науки. Том 01 (114): pp.3-7. https://www.doi.org/10.31618/ESU.2413-9335.2024.4.114.1966
Royal College of Obstetricians and Gynaecologists. (2022). Best practice in abortion care. Published by the Royal College of Obstetricians and Gynaecologists
Strigakov A., Ignatko Y., Davidov V. (2020). Obstetrics. Textbook. ASBOTAR media.
Vico J., J. Pantoja, E. Martins, A. Weichselbaum. (2018). Aqueduct-100, innovador dispositivo y un método para la dilatación cervical controlable. Prog Obstet Ginecol; 61(6):рр.551-555.
World Health Organization. (2022). Abortion care guideline. ISBN 978-92-4-003948-3, Published Creative Commons Attribution-Non Commercial-Share Alike licence (CC BY-NC-SA 3.0 IGO (electronic version) (405).
World Health Organization. (1999). Therapeutic method evaluative changes. Scientific Group report, Geneva (Technical Report series: 871).
World Health Organization. (2014). Library Cataloguing-in-Publication Data. Clinical practice handbook for safe abortion. Scientific Group, Geneva; ISBN 978 92 4 154871 7.
World Health Organization. (2012). Safe Abortion: Technical and Policy Guidance for Health Systems. Second edition, Scientific Group, Geneva.
